Thailand COVID-19 vaccine research programs KinGen Biotech was appointed as one of the key manufacturers to take part in Thailand’s COVID-19 R&D program driven by the National Vaccine Institute, Ministry of Public Health of Thailand. The program foresees scale-up of local R&D vaccine candidates ranging from pDNA, recombinant proteins, viral vectors to plant-based proteins. KinGen […]
HEMAX KinGen Biotech is entering into a collaboration with Berli Jucker PLC and BioSidus S. A. to gradually localize manufacturing technologies of HEMAXTM (Erythropoietin) from Argentina to Thailand. The locally manufactured product was successfully registered at the Thai FDA in August 2020. The consortium is ready to launch the product in Q1 2021.